Heterocyclic Drug-polymer Conjugates for Cancer Targeted Drug Delivery

E-ISSN： 1875-5992|16|11|1355-1377

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.16, Iss.11, 2016-10, pp. : 1355-1377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Drug Delivery for Breast Cancer Treatment

Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Iss. 2, 2013-05 ,pp. : 143-153

Bentham Science Publishers

Access to resources Recommend Favorite

Polymer nanoparticulate drug delivery and combination cancer therapy

By Cao Pengxiao Bae Younsoo

Future Oncology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1471-1480

Future Medicine

Access to resources Recommend Favorite

Antibody–drug conjugates (ADCs)—new targeted therapies

By Papakonstantinou Georgios

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 223-224

Springer Publishing Company

Access to resources Recommend Favorite

Integrin-Targeted Peptide- and Peptidomimetic-Drug Conjugates for the Treatment of Tumors

Recent Patents on Anti-Cancer Drug Discovery, Vol. 12, Iss. 2, 2017-06 ,pp. : 148-168

Bentham Science Publishers

Access to resources Recommend Favorite

Brain Cancer: Implication to Disease, Therapeutic Strategies and Tumor Targeted Drug Delivery Approaches

Recent Patents on Anti-Cancer Drug Discovery, Vol. 13, Iss. 1, 2018-01 ,pp. : 70-85

Bentham Science Publishers

Access to resources Recommend Favorite